Your thoughts on WHO's agenda
On 25-30 January 2016, the Executive Board meeting at the World Health Organization (WHO) takes place in Geneva.
This is a business meeting that checks progress against resolutions and key items from the World Health Assembly (WHA) and ongoing WHO programmes.
Together the Executive Board and WHA define global health issues and create policies which impact on regional decision-making and national health systems around the world. The agenda and papers are available to view on their website. The January meeting agenda covers a full range of global issues and concerns of interest, including ongoing WHO reform and the role of non-state actors, progress in action to address communicable and non-communicable diseases.
Our relationship with WHO
IAPO has official relations with WHO, coordinated through their Patients for Patient Safety work. This grants us certain privileges including attending and making interventions at the WHO Executive Board Meetings and the World Health Assembly, as we did for the Regional Committee meetings in September and October. These meetings are attended by high level delegates from around the world, including Ministers of Health, WHO regional directors, as well as representatives from a range of non-state actors such as academics, philanthropists, industry representatives and civil society. It is therefore a key networking and advocacy opportunity.
Work with us on key issues
It is likely that a Board Member and staff will attend some of the Executive Board meeting, and we invite you to review the agenda and let us know if there are key issues that you are interested in. There may be an opportunity for IAPO to facilitate a small number of members to gain an access pass for the meetings. We cannot make any accommodation or travel arrangements or otherwise support attendance but please contact email@example.com as soon as possible (and by 18 December 2015 at the latest) if you can make your own arrangements and supply a passport style digital photo. Attendance may be limited.